The benefits of early ion channel screening - a podcast by Drug Discovery World (DDW)

The latest sponsored DDW Sitting Down With podcast features Dr Michael Morton, Director and Co-founder, ApconiX, and Dr Kimberly Rockley of ApconiX who discuss the benefits of early ion channel screening. The podcast covers the hERG ion channel and its importance in cardiac safety screening in drug discovery.

Morton and Rockley outline the options available, the advantages of these approaches and how the results of hERG should and could be used to inform the drug discovery pathway.

Listen now.

Further episodes of The Drug Discovery World Podcast

Further podcasts by Drug Discovery World (DDW)

Website of Drug Discovery World (DDW)